01830 PERFECT MEDICAL
Trading Add to PorfolioKey Financial Ratio (Fiscal Year: 03/2025) | |||
Current | 1.18X | Oper Margin | 23.4% |
---|---|---|---|
LT Debt/Equity | 30.6% | Net Margin | 18.3% |
Total Debt/Equity | 57.0% | Return on Equity | 54.5% |
Price/Book | 5.62X | Return on Assets | 22.1% |
(HKD 1.700) | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
Net Profit (MHKD) | 206.90 | 315.80 | 315.64 | 305.25 | 284.63 |
---|---|---|---|---|---|
Net Profit Growth (%) | -34.5 | +0.1 | +3.4 | +7.2 | -21.0 |
Earnings Per Share (HKD) | 0.165 | 0.251 | 0.253 | 0.248 | 0.244 |
Earnings Per Share Growth (%) | -34.5 | -0.5 | +1.9 | +1.9 | -24.5 |
Dividend Per Share (HKD) | 0.166 | 0.315 | 0.300 | 0.248 | 0.380 |
P/E* (X) | 10.32 | 6.76 | 6.73 | 6.85 | 6.98 |
Yield (%) | 9.76 | 18.53 | 17.65 | 14.59 | 22.35 |
Dividend Share (%) | 100.79 | 125.30 | 118.72 | 100.00 | 156.06 |
Book NAV (HKD) | 0.303 | 0.396 | 0.487 | 0.399 | 0.560 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(HKDMn) | 2025-03 | 2024-03 | Chg* (%) | 2023-03 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 1,128 | 1,393 | -19.0 | 1,389 |
Operating Result | 252.549 | 383.723 | -34.2 | 392.556 |
Profit Before Taxation | 252.549 | 383.723 | -34.2 | 391.456 |
Taxation | 46.179 | 73.324 | -37.0 | 75.818 |
Profit /( Loss) After Taxation | 206.37 | 310.399 | -33.5 | 315.638 |
Minority Interests | -0.525 | -5.401 | -90.3 | 0 |
Net Profit | 206.895 | 315.8 | -34.5 | 315.638 |
Earnings Per Share () | 0.1647 | 0.2514 | -34.5 | 0.2527 |
Dividend Per Share () | 0.1660 | 0.3150 | -47.3 | 0.3000 |
Announcement Date | 2025-06-27 | 2024-06-28 | NA | 2023-06-28 |
* Annualised
Last Update Time: 2025-07-22 21:40:25